Suppr超能文献

劳拉西泮和戊巴比妥辨别:与CGS 8216和咖啡因的相互作用。

Lorazepam and pentobarbital discrimination: interactions with CGS 8216 and caffeine.

作者信息

Ator N A, Griffiths R R

出版信息

Eur J Pharmacol. 1985 Jan 2;107(2):169-81. doi: 10.1016/0014-2999(85)90056-1.

Abstract

Baboons and rats were trained under a two-lever, food-reinforced drug discrimination procedure. The training drug was either lorazepam (1.0 mg/kg) or pentobarbital (5.6 mg/kg in baboons, 10.0 mg/kg in rats). Under test conditions, a range of training drug doses occasioned 100% drug lever responding. CGS 8216 (3.2-10.0 mg/kg) combined with lorazepam produced a complete shift to the no-drug lever in both species; this shift was surmountable with higher doses of lorazepam. CGS 8216 (32.0 mg/kg) combined with pentobarbital produced a statistically significant decrease in drug-lever responding in rats, and in baboons CGS 8216 initially, but not subsequently, produced a complete shift to the no-drug lever. Caffeine (0.32-10.0 mg/kg) combined with lorazepam inconsistently decreased drug-lever responding across multiple determinations in baboons and significantly decreased drug lever responding in rats. Caffeine combined with pentobarbital also yielded an inconsistent decrease in drug lever responding in baboons but there was no effect in rats. Thus the most reliable and complete antagonism across species was obtained with the CGS 8216/lorazepam combinations.

摘要

在双杠杆、食物强化的药物辨别程序下对狒狒和大鼠进行训练。训练药物为劳拉西泮(1.0毫克/千克)或戊巴比妥(狒狒中为5.6毫克/千克,大鼠中为10.0毫克/千克)。在测试条件下,一系列训练药物剂量引发了100%的药物杠杆反应。CGS 8216(3.2 - 10.0毫克/千克)与劳拉西泮联合使用在两个物种中均导致完全转向无药物杠杆;这种转变可被更高剂量的劳拉西泮克服。CGS 8216(32.0毫克/千克)与戊巴比妥联合使用使大鼠的药物杠杆反应在统计学上显著降低,在狒狒中,CGS 8216最初导致完全转向无药物杠杆,但随后未出现这种情况。咖啡因(0.32 - 10.0毫克/千克)与劳拉西泮联合使用在狒狒的多次测定中不一致地降低了药物杠杆反应,在大鼠中显著降低了药物杠杆反应。咖啡因与戊巴比妥联合使用在狒狒中也使药物杠杆反应不一致地降低,但对大鼠没有影响。因此,CGS 8216/劳拉西泮组合在不同物种中产生了最可靠和完全的拮抗作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验